为pdf文件创建JSON结构

时间:2019-08-01 11:39:20

标签: json pdf structure

我正在尝试为示例PDF创建JSON结构。我是JSON的新手,我有完成此任务的截止日期。

PDF:Sample Image

  

我的工作:

{"Section":{"Para ID":[{"0":
"if":{"para_type":"text"},

"then":{"para_content":"Toxicokinetic parameters were obtained concurrently with repeat-dose toxicity studies in monkeys \
 and rats and an embryotoxicity study in rats.",

"section_id":"s0","section_title":"Toxicokinetic data","meta_data":"<meta_data>"},
"else": {

"if": {"para_type":"table"},

"then": {"para_content":{"Species":{"0":"Rat","1":"Monkey","2":"Human"},

"Dose_Association":{"0":"HNSTD","1":"NOAEL","2":"proposed dose"},
"Dose_(mg\/kg)":{"0":5.0,"1":3.0,"2":1.8},
"Cmax a_(\u03bcg\/mL)":{"0":"103 \u2013 138","1":"55.4 \u2013 83.8","2":"33.18"},
"AUC 0-\u221e_(day*\u03bcg\/mL)b":{"0":"253","1":"140 \u2013 210 c","2":"82.61"}},
"section_id":"s0","section_title":"Toxicokinetic data",
"table_shape":"<table_shape>",
"table_columns":"<column_names>",

"meta_data":"Table 14: Comparative Systemic Exposure to SGN-35 after Intravenous Administration\
of SGN-35 to Rats, Monkeys, and Humans",

"table_note":"HNSTD: highest non severely toxic dose; \
NOAEL: no observed adverse effect level; a: observed Cmax data are presented from subchronic repeat-dose\
toxicity studies in rats (Report 7646-118) and monkeys (Report 8216375) and from cycles 1 to 9 of phase 1 \
clinical study SG035-00001; b: AUC0-∞ data are presented from the single-dose pharmacokinetic studies in rats\
(Report R-PK-08) and monkeys (Report 8213480) and from cycles 1 to 9 of phase I clinical study SG035-0001;\
c: The range represents the values from primate antihuman antibodies (PAHA)-positive and –negative animals"},
 },
},

{"1":
"if":{"para_type":"text"},

"then":{"para_content":"An overview of the relative exposures to SGN-35 by species is provided in Table 14.\
Exposures associated with the highest non-severely toxic dose (HNSTD) in rats and at the no observed\
adverse effect level (NOAEL) in monkeys are shown. The human exposures reflect the data collected for\
the proposed marketed dose of 1.8 mg/kg. The serum exposure to SGN-35 in rats at the HNSTD was approximately 3 to 4 \
times that in humans. The serum exposure to SGN-35 in monkeys at the NOAEL was \
approximately 2 to 3 times that in humans.",

"section_id":"s0","section_title":"Toxicokinetic data","meta_data":"<meta_data>"},
"else": {
"if": {"para_type":"table"},
"then": {"section_id":"<section_id>","section_title":"<section_title>","table_shape":"<table_shape>",
"table_columns":"<column_names>","meta_data":"<meta_data>"},
 },
}]}}

我希望你们对此进行审查,并帮助我构建结构。

0 个答案:

没有答案
相关问题